Antidepressants Are Associated With a Reduction in the Risk of Death in COVID-19 Disease Patients

Am J Ther. 2023 May 1;30(3):e285-e288. doi: 10.1097/MJT.0000000000001618.

Authors

Raquel Cobos-Campos¹, Arantza Sáez de Lafuente-Moríñigo¹, José Aurelio Cordero-Guevara¹, Cristina Bermúdez-Ampudia¹, Antxon Apiñaniz^{1

2

3

4}, Julene Argaluza¹, Naiara Parraza^{1

2}

Affiliations

¹ Bioaraba Health Research Institute. Epidemiology and Public Health Group. Vitoria-Gasteiz, España.
² Osakidetza Basque Health Service. Aranbizkarra I Health Center. Vitoria-Gasteiz, España.
³ Department of Preventive Medicine and Public Health. University of the Basque Country. Vitoria-Gasteiz, España; and.
⁴ Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Madrid, Spain.

PMID: 36856572
DOI: 10.1097/MJT.0000000000001618

No abstract available

Publication types

Letter

MeSH terms

Antidepressive Agents
COVID-19*
Depression
Humans

Substances

Antidepressive Agents